Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
CuriosityStream | CURI | 5. nov 2024 | 2.41 | +0.84 |
Curis | CRIS | 5. nov 2024 | 4.42 | +2.08 |
CURRENC Group | CURR | 5. nov 2024 | 1.93 | 0.00 |
Curtiss-Wright | CW | 5. nov 2024 | 360.37 | +2.96 |
Cushing Mlp & Infrastructure Total Return Fund | SRV | 5. nov 2024 | 40.52 | +1.12 |
Cushman & Wakefield | CWK | 5. nov 2024 | 15.17 | +15.45 |
Custom Truck One Source | CTOS | 5. nov 2024 | 4.35 | +5.84 |
Customers Bancorp | CUBI | 5. nov 2024 | 46.44 | +1.71 |
Customers Bancorp E Pref | CUBI-E | 5. nov 2024 | 25.87 | +0.47 |
Customers Bancorp F Pref | CUBI-F | 5. nov 2024 | 25.40 | +0.59 |
Cutera | CUTR | 5. nov 2024 | 0.59 | +6.61 |
CVB Financial | CVBF | 5. nov 2024 | 19.31 | +1.85 |
CVD Equipment | CVV | 5. nov 2024 | 2.90 | -0.34 |
CVR Energy | CVI | 5. nov 2024 | 16.39 | -0.30 |
Cvr Partners LP Unit | UAN | 5. nov 2024 | 66.97 | +0.39 |
CVRx | CVRX | 5. nov 2024 | 15.42 | +2.46 |
CVS Health | CVS | 5. nov 2024 | 55.34 | +1.26 |
CXApp A | CXAI | 5. nov 2024 | 1.41 | +4.44 |
CyberArk Software | CYBR | 5. nov 2024 | 280.19 | +2.22 |
Cybin | CYBN | 5. nov 2024 | 10.15 | +0.30 |
Cyclacel Pharmaceuticals | CYCC | 5. nov 2024 | 0.44 | -12.46 |
Cyclacel Pharmaceuticals Pref | CYCCP | 5. nov 2024 | 6.82 | -9.07 |
Cyclerion Therapeutics | CYCN | 5. nov 2024 | 2.77 | +5.02 |
Cyclo Therapeutics | CYTH | 5. nov 2024 | 0.71 | -3.29 |
Cyngn | CYN | 5. nov 2024 | 3.98 | +8.31 |
Cytek Biosciences | CTKB | 5. nov 2024 | 5.44 | +4.62 |
Cytokinetics | CYTK | 5. nov 2024 | 52.52 | +2.02 |
Cytomed Therapeutics | GDTC | 5. nov 2024 | 2.62 | +5.64 |
CytomX Therapeutics | CTMX | 5. nov 2024 | 0.99 | -1.68 |
Cytosorbents | CTSO | 5. nov 2024 | 0.86 | -0.95 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.